Request Your Free Trend Report Now:

"Inside the growing treatment market for rare diseases"

The story of the rare disease market in recent years has been centered around growth with large pharmas starting to see more promise in the space as deals tick up.

In drug development, rare disease represents one of the most urgent and complex areas of opportunity. Explore how regulatory shifts, pricing challenges, and innovation in ultra-rare conditions are reshaping business strategies for rare diseases in this Trendline.

Included in this trendline :

• Novartis’ Zolgensma sales fall again as gene therapy market woes persist
• FDA’s new mission to speed drug reviews
• How a patient group tackled research diversity for one disease and triggered change for pharma

Offered Free by: PharmaVoice and Advanced Clinical
See All Resources from: PharmaVoice and Advanced Clinical